40th Congress of the Société Internationale d'Urologie
October 10-11, 2020, Virtual

SIU 2020 Virtual Congress Scientific Programme

Behind the scenes, much work has been done to modify the existing SIU 2020 programme that had been designed for an in-person meeting to adapt to the new reality of virtual presentation. The SIU and Scientific Programme Co-Chairs, Drs Christopher Evans and Rajeev Kumar, thank all programme Chairs and Faculty who have contributed much of their time and expertise over the past 18 months. The programme for SIU 2020 Virtual will cover a wide range of topics and continue to offer the high-quality educational content that SIU attendees have come to expect. We invite you to take a look at the programme schedule that will be presented on the SIU@U platform and start planning your agenda for October 10-11, 2020.

 

The 2020 Congress Learning Objectives are as follows:

After this educational event, attendees should be able to:

  • Determine diagnosis and management of basic and complicated urological infections
  • Describe the role of eHealth, new diagnostic methods and delivery of urological education and care in the developing world
  • Summarize recent advances in molecular markers for urological diseases
  • Report the application of therapeutic modalities and management of complex stone disease
  • Discuss approaches to treatment of urological cancers
  • List recent advances in minimally invasive surgery
  • Describe the current management of lower urinary tract symptoms
  • Identify methods of dissemination of knowledge and care to underserved areas.

 

SIU 2020 Scientific Programme

Please Note: All session times are listed in Eastern Standard Time (EST).

Saturday, October 10

0130-0215

Plenary-Asia/Oceania

0130-0145

UAA lecture: Management of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients
Kyu-Sung Lee, South Korea

Method: Lecture

0145-0215

SIU-ICUD/WUOF Molecular Biomarkers in Genitourinary Cancers
Co-chairs: Laurence Klotz, Canada/ Yair Lotan, United States/ Jack Schalken, Netherlands/ Nathan Lawrentschuk, Australia

At the end of this session, attendees will be able to review:
• Review the approach taken in the development of the new ICUD on Molecular Biomarkers in Urologic Oncology
• Review recent highlights in the development and incorporation into practice of biomarkers in prostate cancer
• Review recent highlights in the development and incorporation into practice of biomarkers in kidney  cancer
• Review recent highlights in the development and incorporation into practice of biomarkers in bladder cancer
Method: Lectures

0300-0400

Joint SIU-International Society of Reconstructive Urology (ISORU)/Society of Genitourinary Reconstructive Surgeons (GURS) session – Topic: Anterior Urethroplasty
Co-Chairs: Sanjay Kulkarni, India/ Jeremey Myers, United States
Moderators: Andre Cavalcanti, Brazil, Francisco Martins, Portugal, Jill Buckley, United States

At the end of this session, attendees will be able to:

  • Describe the potential advantages of Non-transecting bulbar urethroplasty in regards to preservation of bulbar arterial flow and preservation of erectile function.
  • Outcomes of ventral placement of buccal graft for fossa navicularis strictures and the technique for this surgery.
  • Describe various approaches for salvage hypospadias repair in adults and how to approach primary hypospadias repair in adults. Contrast differences in adult surgery versus children.

Method: Lectures and discussion

0300-0400

Controversies 01 - New Challenges in Imaging and Management of Oligometastatic Prostate Cancer
Co-Chairs: Prasanna Sooriakumaran, United Kingdom/ Derya Tilki, Germany

At the end of this session, attendees will be able to:

  • The delegates will learn about controversies in the definition of oligometastatic prostate cancer and standard and novel imaging modalities to define it.
  • The delegates will learn about treatment options in the management of oligometastatic prostate cancer and current controversies in choice of management.
  • The delegates will understand current best practice data and learn about emerging clinical trials in oligometastatic prostate cancer.

Method: Debate 

0500-0600

Plenary-Europe/Africa

0500-0515
European Association of Urology lecture: Adoption of New Techniques for the Treatment of Benign Prostatic Obstruction: What Are the Requirements?
Stavros Gravas, Greece

At the end of Dr. Gravas’ lecture, attendees will be able to:

  • Summarize the needs of patients and clinicians for minimally invasive surgery for the management of BPO
  • Understand how to assess the certainty of evidence for new treatment modalities
  • Discuss the criteria that a new therapy should meet for widespread implementation
  • Apply the gained knowledge in order to better inform their patients about the available therapies for BPO.

Method: Lecture

0515-0530
Pan African Urological Surgeons’ Association lecture: Reconstructive Urology for Complex Obstetrics Fistulae
Serigne Gueye, Senegal

Method: Lecture

0530-0545
Burnout in Urological Training
Tobias Kohler, United States

At the end of Dr. Kohler’s lecture, attendees will be able to:

  • Understand the definition and prevalence of burnout in Urology
  • Take away several strategies to minimize and mitigate burnout in Urology
    Method: Lecture

0545-0600
HIV & Circumcision lecture
Timothy Hargreave, United Kingdom

At the end of Dr. Hargreave’s lecture, attendees will be able to:

  • Understand male circumcision and public health HIV prevention
    • An example of application of ecological and clinical trial data into public health practice
    • Remains controversial because of strongly held personal views
    • Strong scientific evidence that Male circumcision provides a 60% protective effect against heterosexual transmission of HIV from female to male
    • Public health benefit not affected by viral resistance to drugs or interruptions in drug supply chains
    • 25 million adult and adolescent male circumcisions in East and Southern Africa represent one of the largest ever application of surgery to combat an infectious disease
    • Not an appropriate intervention for countries with low HIV prevalence
    • Minimal if any protective effect for men who have sex with men
    Method: Lecture

 

0600-0700

Instructional Course 01 - Lower Urinary Tract Symptoms and Urinary Tract Infections in Children
Chair: M. Ihsan Karaman, Turkey

At the end of this session, attendees will be able to:

  • Understand diagnosis and management of basic and complicated urological infections in children,
  • Describe the current management of lower urinary tract dysfunction with or without UTI in children,
  • Have an overview on common pediatric urological conditions of the urinary tract,
  • Have a general idea about medical, minimally invasive, and surgical management of pediatric lower urinary tract dysfunction and infections,
  • Manage some of the common pediatric urological diseases medically.

Method: Lecture

0700-0800

Instructional Course 02 - Gender Affirmation Surgery: Role of the Urologist
Chair: Miroslav Djordjevic, Serbia

At the end of this session, attendees will be able to:

  • Define the role of urologist in gender affirmation surgery.
  • Report the recent surgical modalities in both, male to female and female to male gender affirming surgery.
  • Recognize most important surgical steps in male-to-female and female-to-male gender affirmation
    surgery; define and achieve successful outcome.
  • Summarize possible postoperative complications
  • Conduct postoperative urethral problems in transmen and present the options for correction.
  • Recognize urological complications after male to female transgender surgery and describe the current management.

Method: Lectures

0800-0900

Master Class 01 - Hypospadias Surgery for the General Urologist
Co-Chairs: Joao Pippi Salle, Canada/ Rados Djinovic, Serbia

At the end of this session, attendees will be able to:

  • Present and discuss the main anatomic characteristics that influence the decision for technical repairs
  • Elaborate the rationale for pre-operative use of hormone stimulation and peri-operative antibiotic prophylaxis
  • Present technical details for repair of primary as well as redo hypospadias, including utilization of videos
  • Promote ample discussion about follow up as well as the main post op complications
  • Comment on possible differences for treatment of hypospadias in children and in the post pubertal period

Method: Live-streamed session with a moderator

Moderator: Aseem Shukla, United States

0930-1045

Plenary-Americas

0930-0945
Canadian Urological Association lecture: Oncology/Robotics
Robert Hamilton, Canada

At the end of Dr. Hamilton’s lecture, attendees will be able to:
• Understand the current state of evidence supporting robotic approaches to prostate, kidney, bladder, and testis cancers
• Learn about data  pertaining to how COVID-19 may impact laparoscopic and robotic surgery
• Explore how novel robotic platforms may alter access, utilization, and cost-effectiveness
Method: Lecture

0945-1000

State of the Art (SOA) Lecture: How Surgical Volunteerism and Humanitarian Outreach Can Enhance Care in Underserved Populations
Joseph A. Smith, United States

At the end of Dr. Smith’s lecture, attendees will be able to:

  • Understand opportunities for international surgical volunteerism
  • Learn how to transfer advanced surgical skills to local surgeons.
  • Explore ways that new technology can be introduced to low resource countries

Method: State of the art lecture

1000-1015
State of the Art (SOA) Lecture: Gender Issues in Urology
Maria Ribal, Spain

At the end of Dr. Ribal’s lecture, attendees will be able to:

  • Learn about figures/epidemiology of gender distribution in Medicine
  • Learn gender discrepancies in scientific community
  • Learn about gender inequalities on surgery and urology
  • Learn how to address female participation in the field of urology.

Method: State of the art lecture

1015-1030
Confederación Americana de Urología lecture: Management of Double Collecting System Pathology in Children
Juan C. Prieto, United States

At the end of Dr. Prieto’s lecture, attendees will be able to:
• Identify the surgical indications for the management of double collecting systems in children.
• Select the appropriate diagnostic studies to approach double collecting systems in children.
• Define the surgical options for the management of ectopic ureters and ureteroceles in children.
Method: Lecture

1030-1045
AUA lecture: Immunotherapy/New drugs
E. Jason Abel, United States

Method: Lecture

1100-1200

Instructional Course 03 - Lymphadenectomy in Urologic Cancer
Co-Chairs: George Thalmann, Switzerland/ Sia Daneshmand, United States

At the end of this session, attendees will be able to:

  • Identify patients in need of lymphadenectomy in urological cancers
  • Apply the correct template for lymphadenectomy and their extension
  • Recognize the techniques used and potential complications of lymphadenectomy in urological cancers

Method: Lecture and discussion

1100-1200

Master Class 03 - New Technologies in Stone Removal
Co-Chairs: Petrisor Geavlete, Romania/ Amy Krambeck, United States

At the end of this session, attendees will be able to:
• Describe and determine the proper laser settings for different type of stone fragmentation approaches for ureteroscopic stone removal
• Evaluate the benefits and limitations of the different devices currently available for percutaneous stone removal
• Describe the current accepted approaches and new approaches to percutaneous stone access
• Determine the appropriate use of different types of ureteral access, scopes and stone retrieval devices for ureteroscopic stone removal
Method: Lecture

1430-1530

Interactive Session 01 - Erectile Dysfunction and Peyronie’s Disease: What’s Best for Whom?
Co-Chairs: Gerald Brock, Canada/ Drogo Montague, United States

At the end of this session, attendees will be able to:
• Determine the diagnosis and management of  complicated cases of Penile Curvature caused by Peyronie's Disease
• Understand the existing scientific evidence related to use of evolving therapeutic modalities such as stem cell and low energy shockwave treatments in erectile dysfunction and their clinical utility
• Understand the role of medical pharmacotherapy, surgery and traction therapy in men with ED and penile1 deformity 
Method: Lecture and discussion

1900-2000

Master Class 02 - Genomic Testing and Recurrence in Prostate Cancer
This session is supported by an unrestricted educational grant.
Co-Chairs: Shusuke Akamatsu, Japan/ Marc Dall’Era, United States

At the end of this session, attendees will be able to:
• Recognize when to order genomic testing in prostate cancer treatment
• Determine who is expected to benefit from treatment with PARP inhibitors
• Explain the importance of genetic counseling
• State the current status and future prospect of liquid biopsy
Method: Lecture and discussion

Sunday, October 11

0230-0250

Joint SIU- International Continence Society (ICS) session
Co-Chairs: David Castro-Diaz, Spain/ Stavros Charalampous, Cyprus

At the end of this session, attendees will be able to:

  • To provide important information on LUTS, that they have a significant impact on the quality of life (QoL) on elderly population while there is a separate consideration from men due to the anatomical and functional differences in the lower urinary tracts between both genders and consequent differences in pathologies affecting them.
  • Rational therapeutics is dependent on a sound understanding of the causes and consequences of variability in responses to medicines. Older people display considerable variability in response to medicines, making the optimization of dosage complex.

Method: Lectures


0300-0400

Master Class 04 - Establishing Standardized Outcome Reporting in Your Urology Practice
Co-Chairs: Matt Cooperberg, United States/ Ghulam Nabi, United Kingdom

At the end of this session, attendees will be able to:

  • Describe various components of high-quality urologic care, in terms of both processes and outcomes
  • Identify existing and emerging data registries to facilitate reporting of outcomes for urologic care
  • Plan for eventual mandated and/or public reporting of quality of care data
  • Assess and appraise existing literature in their area of urological conditions care
    Method: Lectures

0400-0420

Joint SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) session
Co-Chairs: Christopher Evans, United States/ Morgan Roupret, France

At the end of this session, attendees will be able to:

  • Identify the surgical approach, morbidity, and outcomes of radical cystectomy in locally advanced disease.
  • Understand indications, response rates and toxicities of chemotherapy and immunotherapy in urothelial cancer.
  • Identify the pros and cons of nephron sparing surgery in stage T2 renal cell carcinoma.
  • Discuss the management options, risks, and benefits of therapeutic approaches (kidney sparing surgery vs. radical NU) for upper tract urothelial carcinoma.
  • Understand the relevant germline and somatic mutations in patients with advanced prostate cancer and the therapeutic implications.

Methods: Lectures

 

0400-0500

Controversies 02 - Controversies in the Management of Kidney Cancer
Co-Chairs: Surena Matin, United States/ Amlesh Seth, India

At the end of this session, attendees will be able to:
• Realise that metastatic Kidney cancer is not a single disease with uniform prognosis. Therefore, the management strategy has to be individually tailored.
• The session will educate attendees regarding the advantages and disadvantages of cytoreductive nephrectomy. The indications, timing, and integration of cytoreductive nephrectomy with systemic therapy will be discussed.
• The attendees will be able to debate the advantages and disadvantages of open vs robotic partial nephrectomy. The session should help choose the right approach for the right patient in the right setting.
• The third component of case-based discussion will clarify the nuances of practically managing localized and metastatic kidney cancer.
Methods: Case presentations and debate

0430-0530

Interactive Session 02 - Penile Cancer Management including Organ Sparing Approaches
Co-Chairs: Nicola Nicolai, Italy/ Curtis Pettaway, United States
Panelists: Pierre Blanchard, France/ Philippe Spiess, United States/ Steve Nicholson, United Kingdom

At the end of this session, attendees will be able to:

  • Understand the importance of pathologic stage, tumor location, and histologic variables in determining treatment options for the primary tumor
  • Describe the different approaches to managing the primary penile tumor
  • Discuss the importance and options for accurately determining inguinal lymph node status among patients with invasive primary tumors and no palpable inguinal adenopathy
  • Discuss current Multimodality treatment options among patients presenting with bulky regional adenopathy from penile cancer.

Method: Panel and discussion

0500-0600

Instructional Course 04 - The Current Situation of Antimicrobial-Resistant Pathogens in Urological Fields
Co-Chairs: Satoshi Takahashi, Japan/ Koichiro Wada, Japan

At the end of this session, attendees will be able to:

To understand the current situation of antimicrobial-resistant pathogens and management for UTI caused by antimicrobial-resistant pathogens.

 

0530-0630

Instructional Course 05 - Metabolic Work Up and Medical Treatment of Stones
Chair: Mohamed Elshazly, Egypt

At the end of this session, attendees will be able to:
• Learn the basics and practical simplified algorithm of metabolic workup and medical treatment.  This
will be presented in a simplified practical way without digging into the dilemma of theories and controversies in this tough topic.
• To know the updated medical treatment protocols for different types of stones

Method: Lectures

0600-0700

Instructional Course 06 - Urethral Stricture Surgery
Chair: Sanjay Kulkarni, India

At the end of this session, attendees will be able to:

  • Determine criteria for reconstruction based on location and etiology of the stricture
  • Recall essential techniques for simple and complex anterior urethral reconstruction
  • Apply innovations in penile and bulbar urethral stricture management
  • Summarize preoperative and intraoperative preparation for posterior urethroplasty cases after
    pelvic fracture urethral injury

 

0630-0650

Joint SIU- Endourology Session
Co-Chairs: Mahesh Desai, India/ Jorge Gutierrez, United States

At the end of this session, attendees will be able to:

  • Learn different endoscopic surgical techniques for endourology procedures
  • Understand the advantages and limitations of percutaneous and ureteroscopic surgeries
  • Recognize the best surgical candidates for endoscopic surgery, specifically understand the indications and limitations of the techniques based on stone size and burden
  • Understand the different products used for percutaneous and ureteroscopic procedures including access, dilation, stone fragmentation and stone removal
  • Learn how to properly evaluate and treat patient with endourologic surgeries

Methods: Update in different topics of Endourology will be discussed in this joint session. Emphasis will be placed on the indications, limitations, advantages, and description of the different surgical techniques. Faculty will share tips on their surgical techniques as well as tricks for a successful outcome with endourology procedures.

 

0730-0830

Instructional Course 07 - The Many Phenotypes of Neurogenic Bladder
Co-Chairs: Blayne Welk, Canada/ John Stoffel, United States

At the end of this session, attendees will be able to:

• Describe the many causes of neurogenic bladder
• Detail the various clinical presentation of lower urinary tract symptoms and corresponding urodynamic findings of neurogenic bladder
• Connect the causes, clinical presentation, and management into phenotypic groups.
Method: Lectures

0830-0930

Instructional Course 08 - Urologic Endoscopy in Resource Restricted Environments
Chair: Kymora Scotland, United States

At the end of this session, attendees will be able to:

  • Learn to define optimal use of instruments in challenging environments
  • Understand and compare cost saving practices
  • Define and recognize risk from cost saving practices
  • Learn of innovations aimed at improving cost saving measures

 

0830-0930

Instructional Course 09 - e-Health, Digital Health, Telemedicine: Tele-urology 101—Getting Connected   
Co-Chairs: Emmanuel Abara, Canada/ Michael Borofsky, United States

At the end of this session, attendees will be able to:

  • Define such terms: e-Health, Telemedicine, Telehealth, Digital Health and Health Informatics
  • Enumerate various types of patient-centred Tele-urology services- e-Visits, Video- Conferencing, e-consults, Tele-monitoring, Tele-Simulation/Tele surgery, Tele-mentoring; and identify how technology can be useful in dissemination of knowledge and care to underserviced and remote communities.
  • Categorize Telemedicine Delivery Modes-Networks, Organizations, examples, ATA, OTN, ISfTeH; point-to-point connectivity, Bridging, with emphasis on Mobile Health Technology
  • Discuss regulatory and key legal and privacy considerations as applicable in various jurisdictions Analyze processes of re-imbursement for services rendered through e-Health and Telemedicine
  • Recognize the opportunities and challenges of setting up a Tele-urology service in own Community and world-wide

Method: Case-based discussions and didactic talks.

 

1000-1045

SIU Innovators - Prostate Cancer Debate
This session is supported by an unrestricted educational grant.
Moderator: Siska van Bruwaene, Belgium

At the conclusion of this activity, participants will be able to

  • Select the correct therapeutic strategy for patients with localized prostate cancer, depending on different patient and tumor characteristics.
  • List the advantages and disadvantages of prostate biopsy strategies.
  • Explain the use of PSMA scan in different clinical settings.
  • List all the advantages and disadvantages of performing lymph node dissection in prostate cancer patients.

Method: Live-streamed session, debate format

1130-1150

Joint SIU- Society of Urologic Robotic Surgeons (SURS) session
Chairs: Jihad Kaouk, United States

At the end of this session, attendees will be able to:

  • State what is new in Robotic Surgical treatment of Kidney, Prostate, and bladder Cancer
  • Recognize new emerging procedures in robotic surgery
  • Recall technical tips and tricks for current robotic procedures

Methods: Lectures

1300-1400

Master Class 05 - Renal Transplantation
Co-Chairs: William Nahas, Brazil/ Puneet Sindhwani, United States

1400-1530

Instructional Course 17 - A Multidisciplinary Team Approach to the Treatment of Urothelial Carcinoma in the age of Anti-PD1 Agents
This session is supported by an unrestricted educational grant.

Chair: Shaheen Alanee, United States

At the end of this session, attendees will be able to:
• Recognize the role of the multidisciplinary team (MDT) approach in the patient journey through treatment with immunotherapy for advanced bladder cancer
• Receive an introduction to systemic Immunotherapy in bladder cancer
• Role of the MDT in identifying and managing immune-related side effects associated with anti-PD1 agents
• Understand the Importance of interdisciplinary communication and education in preventing life-threatening complications

Method: Lecture and discussion

 

Abstract Submission
Register Now
Abstract Deadline
Follow Us

Twitter feed
JOIN THE SIU COMMUNITY